Home » Topics » BioWorld Science

BioWorld Science
RSS

Recruitment open for phase IIa study of Nerofe for AML and MDS

July 13, 2018

Roche presents phase II data for olesoxime in patients with SMA

July 13, 2018

Shenzhen Chipscreen Biosciences patents indoleamine 2,3-dioxygenase 1 inhibitors

July 13, 2018

Lilly presents IDH1 and IDH2 mutant inhibitors

July 13, 2018

N-Acetyl-beta-D-glucosaminidase inhibitors identified at Janssen

July 13, 2018

Ono Pharmaceutical initiates phase I study of ONO-5788

July 13, 2018

Audentes Therapeutics presents phase I/II data on AT-132 for XLMTM

July 13, 2018

Positive topline data presented from second pivotal phase III study of ZX-008 in Dravet Syndrome

July 13, 2018

Yale University develops novel SV2A radiotracer for PET imaging of synaptic density

July 13, 2018

Astellas' phase I study of ASP-1948 in advanced solid tumors enrolling patients

July 13, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
Other news to note for May 1, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: AC Immune, Aptose, Astrazeneca, Bioreference Health, Cardioline,...